IL-15 and IL-23 synergize to trigger Th17 response by CLA+ T cells in psoriasis

Exp Dermatol. 2020 Jul;29(7):630-638. doi: 10.1111/exd.14113. Epub 2020 May 31.

Abstract

IL-15 has emerged as a potentially relevant target in the IL-17 response in psoriasis. However, its mechanism is poorly characterized in humans. IL-15 and IL-23 are constitutively expressed in the psoriatic lesion. Also, IL-15 is considered a susceptibility-associated gene in psoriasis, as are IL-23R, and HLACW6. Here, we studied the effect of IL-15 and IL-23 stimulation on the cytokine response of CLA+/CLA- T cells from 9 psoriasis patients and 3 healthy control subjects. To this end, CLA + and CLA- T cells from blood samples were cultured with epidermal cells from skin biopsies and treated with IL-15 and IL-23. After five days of culture, cytokines in supernatant were measured by ELISA or fluorescent bead-based immunoassay. There was a statistically significant increase in IL-17F and IL-17A production (P < .001) in cocultures of psoriasis skin-homing CLA + T cells with epidermal cells when stimulated with IL-15 and IL-23, but this effect was not observed in the cells of healthy controls. Interestingly, this response was reduced by around 50 to 80% by blocking HLA class I and II molecules. Our results point to the synergic action of IL-15 and IL-23 selectively for CLA + cells in psoriasis, leading to the induction of Th17 cell-related cytokines.

Keywords: CLA; IL-15; IL-23; Th17; psoriasis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / pharmacology
  • CD4-Positive T-Lymphocytes / metabolism
  • Coculture Techniques
  • Epidermal Cells
  • HLA-DR Antigens / metabolism
  • Histocompatibility Antigens Class I / metabolism
  • Humans
  • Interferon-gamma / metabolism
  • Interleukin-15 / antagonists & inhibitors
  • Interleukin-15 / metabolism
  • Interleukin-15 / pharmacology*
  • Interleukin-17 / metabolism
  • Interleukin-23 / metabolism
  • Interleukin-23 / pharmacology*
  • Interleukin-23 Subunit p19 / antagonists & inhibitors
  • Interleukin-23 Subunit p19 / metabolism
  • Lymphocyte Activation / drug effects
  • Memory T Cells / metabolism*
  • Oligosaccharides / metabolism
  • Primary Cell Culture
  • Psoriasis / immunology*
  • Psoriasis / metabolism*
  • Recombinant Proteins / pharmacology
  • Sialyl Lewis X Antigen / analogs & derivatives
  • Sialyl Lewis X Antigen / metabolism

Substances

  • 6-sulfo sialyl Lewis X
  • Antibodies, Neutralizing
  • HLA-DR Antigens
  • Histocompatibility Antigens Class I
  • IL15 protein, human
  • IL17A protein, human
  • IL17F protein, human
  • IL23A protein, human
  • Interleukin-15
  • Interleukin-17
  • Interleukin-23
  • Interleukin-23 Subunit p19
  • Oligosaccharides
  • Recombinant Proteins
  • Sialyl Lewis X Antigen
  • Interferon-gamma